Department of Orthopaedic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Department of Hand Surgery, The Second Hospital of Fuzhou Affiliated to Xiamen University, Fuzhou, China.
Orthop Surg. 2020 Apr;12(2):463-470. doi: 10.1111/os.12641. Epub 2020 Mar 11.
To report on our clinical outcomes and on the experience of managing acute periprosthetic joint infection (PJI) with debridement, antibiotics, and implant retention (DAIR).
We performed a retrospective review of all patients who were diagnosed with acute PJI after primary hip or knee replacement surgeries and who were managed with DAIR in our prospective joint replacement registry from 2008 to 2019. The diagnosis of PJI was made according to the 2011 Musculoskeletal Infection Society (MSIS) criteria. The symptom onset duration, inflammatory marker levels (i.e. C-reactive protein [CRP], erythrocyte sedimentation rate [ESR], white cell count [WBC], and synovial WBC count), functional scores including the Knee Society Score (KSS), the KSS functional score and the Harris Hip Score (HHS), bacteriology, and surgical outcomes of the patients were tracked and recorded. A paired sample of joint fluid and tissues was also sent for a metagenomic next-generation sequencing (mNGS) test. A paired-samples t-test was used to compare the differences in the inflammatory markers and functional scores before and after surgery.
A total of 24 patients with 7 infections after hip replacements and 17 infections after knee replacements were included. A total of 21 patients exhibited early postoperative infections, and 3 exhibited late acute hematogenous infections. During a mean follow-up time of 29.2 ± 15.1 months, 22 patients were successfully treated, whereas 2 patients were unsuccessfully treated and required repeated DAIR. The overall success rate of DAIR was 91.7%. For staphylococcal infections, DAIR had a 100% success rate. Five patients who presented with symptoms between 4 and 8 weeks also achieved a 100% success rate. At the last follow-up, the mean CRP level decreased from 52.6 ± 34.0 to 5.4 ± 3.5 (P < 0.001), and the mean ESR level decreased from 72.3 ± 34.3 to 20.2 ± 12.1 (P < 0.001). The mean KSS score increased from 44.8 ± 12.2 to 81.4 ± 9.2 (P < 0.001), and the mean KSS functional score increased from 38.1 ± 3.5 to 73.9 ± 23.0 (P < 0.001), and the mean HHS score increased from 34.4 ± 6.9 to 84.1 ± 15.1 (P < 0.001). The overall pathogen identification rate was 91.7% (22/24 cases). The success rates for Staphylococcus, Streptococcus, and the other pathogens were 100% (9/9 cases), 71.4% (5/7 cases), and 100% (6/6 cases), respectively.
Debridement, antibiotics, and implant retention has a high success rate for the treatment of acute PJI and may be performed in selected patients whose symptoms have been sustained for over 4 weeks. A high rate of success for staphylococcal infections was reported with the use of DAIR.
报告我们的临床结果和管理急性假体周围关节感染(PJI)的经验,包括清创术、抗生素和保留植入物(DAIR)。
我们对 2008 年至 2019 年在我们的前瞻性关节置换登记处接受初次髋关节或膝关节置换术后诊断为急性 PJI 并接受 DAIR 治疗的所有患者进行了回顾性分析。PJI 的诊断根据 2011 年肌肉骨骼感染学会(MSIS)标准。跟踪和记录了患者的症状发作持续时间、炎症标志物水平(即 C 反应蛋白[CRP]、红细胞沉降率[ESR]、白细胞计数[WBC]和滑膜 WBC 计数)、功能评分,包括膝关节协会评分(KSS)、KSS 功能评分和髋关节评分(HHS)、细菌学和手术结果。还对关节液和组织的配对样本进行了宏基因组下一代测序(mNGS)检测。使用配对样本 t 检验比较手术前后炎症标志物和功能评分的差异。
共纳入 24 例髋关节置换术后 7 例感染和 17 例膝关节置换术后感染的患者。21 例患者表现为早期术后感染,3 例患者表现为晚期急性血源性感染。在平均 29.2±15.1 个月的随访期间,22 例患者成功治疗,2 例患者治疗失败并需要重复 DAIR。DAIR 的总体成功率为 91.7%。对于葡萄球菌感染,DAIR 的成功率为 100%。5 例症状持续 4 至 8 周的患者也取得了 100%的成功率。末次随访时,CRP 水平从 52.6±34.0 降至 5.4±3.5(P<0.001),ESR 水平从 72.3±34.3 降至 20.2±12.1(P<0.001)。KSS 评分从 44.8±12.2 增加到 81.4±9.2(P<0.001),KSS 功能评分从 38.1±3.5 增加到 73.9±23.0(P<0.001),HHS 评分从 34.4±6.9 增加到 84.1±15.1(P<0.001)。总体病原体检出率为 91.7%(22/24 例)。葡萄球菌、链球菌和其他病原体的成功率分别为 100%(9/9 例)、71.4%(5/7 例)和 100%(6/6 例)。
清创术、抗生素和保留植入物治疗急性 PJI 的成功率较高,对于症状持续 4 周以上的患者可选择使用。DAIR 治疗葡萄球菌感染的成功率较高。